The therapeutic challenge of late antibody-mediated kidney allograft rejection.
Böhmig, Georg A
The therapeutic challenge of late antibody-mediated kidney allograft rejection. [electronic resource] - Transplant international : official journal of the European Society for Organ Transplantation Aug 2019 - 775-788 p. digital
Publication Type: Journal Article; Review
1432-2277
10.1111/tri.13436 doi
Allografts--immunology
Animals
Antibodies, Monoclonal, Humanized
Bortezomib--therapeutic use
Graft Rejection--immunology
Graft Survival--drug effects
Histocompatibility
Humans
Immunoglobulins, Intravenous--therapeutic use
Immunosuppressive Agents--therapeutic use
Isoantibodies--blood
Kidney Transplantation
Proteasome Inhibitors
Randomized Controlled Trials as Topic
Rituximab--therapeutic use
Transplantation, Homologous
The therapeutic challenge of late antibody-mediated kidney allograft rejection. [electronic resource] - Transplant international : official journal of the European Society for Organ Transplantation Aug 2019 - 775-788 p. digital
Publication Type: Journal Article; Review
1432-2277
10.1111/tri.13436 doi
Allografts--immunology
Animals
Antibodies, Monoclonal, Humanized
Bortezomib--therapeutic use
Graft Rejection--immunology
Graft Survival--drug effects
Histocompatibility
Humans
Immunoglobulins, Intravenous--therapeutic use
Immunosuppressive Agents--therapeutic use
Isoantibodies--blood
Kidney Transplantation
Proteasome Inhibitors
Randomized Controlled Trials as Topic
Rituximab--therapeutic use
Transplantation, Homologous